Reckitt Extends Mucinex, Airborne Lines In Global Consumer Expansion
This article was originally published in The Tan Sheet
Executive Summary
The U.K. firm extends Mucinex outside the decongestant category to treating allergies, where the brand faces strong branded and private label competition. An Airborne supplement line extension and wider distribution of MegaRed omega-3 products also factor in the firm’s 2014 consumer health care plans.
You may also be interested in...
Mucinex Ads Cast Consumers As Heroes Fighting ‘Mr. Mucus’
RB revamps advertising for Mucinex for the first time in 10 years to encourage consumers to kick butt during the cold and flu season. The new campaign still includes the green ne'er-do-well “Mr. Mucus,” but gives him a slightly gentler personality and a three-dimensional body.
Mucinex Ads Cast Consumers As Heroes Fighting ‘Mr. Mucus’
RB revamps advertising for Mucinex for the first time in 10 years to encourage consumers to kick butt during the cold and flu season. The new campaign still includes the green ne'er-do-well “Mr. Mucus,” but gives him a slightly gentler personality and a three-dimensional body.
Reckitt’s Schiff Buy Reflects Nutritional Industry “On Fire”
Reckitt Benckiser went high with its $1.4 billion bid for Schiff Nutrition, though the acquisition’s impressive multiples are not entirely out of line with earlier deals in the nutrition space. Analyst Damian Witkowski notes that Airborne, MegaRed and other Schiff brands already are primed for organic growth.